The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

UB researcher Murali Ramanathan has used artificial intelligence (AI) since its nascent days while exploring possible treatments for multiple sclerosis (MS) and Alzheimer’s disease. Today, Ramanathan, ...

Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

At UMass Chan Medical School, gene therapy researchers Terence R. Flotte and Robert H. Brown are trying to figure out how to treat amyotrophic lateral sclerosis, the fatal neurodegenerative condition ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

New Rochelle, NY, October 17, 2025—Mary Ann Liebert, Inc., is pleased that Wai Hong (Kevin) Lo, PhD, has been appointed the new Editor-in-Chief of the journal ASSAY and Drug Development Technologies.

A research team has developed an innovative technique that enables precise modification of specific proteins within complex biological environments. A research team led by Professor Seung Soo Oh and ...